Carcinoma in situ of the skin of the unspecified lower limb, including the hip, is a non-invasive malignancy characterized by abnormal growth of skin cells. This condition is clinically significant as it can progress to invasive cancer if left untreated. Accurate coding with ICD-10 Code D04.70 facilitates precise diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.
ICD-10 Code D04.70 represents carcinoma in situ of the skin located on the unspecified lower limb, including the hip. This code is used when documenting cases of non-invasive skin cancer that has not yet spread beyond the epidermis. It is essential for accurate clinical documentation and billing, particularly in outpatient and surgical settings.
Carcinoma in situ of the skin of the unspecified lower limb, including the hip, is primarily caused by prolonged exposure to ultraviolet radiation, genetic predisposition, and other environmental factors. It is crucial to identify and treat this condition promptly to prevent progression to invasive cancer.
ICD-10 Code D04.70 is utilized in SOAP notes to document the presence of carcinoma in situ, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code D04.70 connects subjective reports of skin lesions with objective clinical findings, facilitating a formal diagnosis. This code supports continuity of care, accurate billing, and adherence to EHR documentation standards.
Prompt treatment of carcinoma in situ is essential to prevent progression to invasive cancer. Treatment options may include surgical excision, cryotherapy, or topical chemotherapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D04.70 is critical for accurate billing in hospital, ER, or outpatient settings, ensuring proper reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 11400 | Excision, benign lesion, face, ears, eyelids, scalp; excised diameter up to 1.0 cm. |
| 17000 | Destruction, premalignant skin lesions (e.g., actinic keratosis); first lesion. |
| 99213 | Established patient office visit, Level 3. |
Common Questions About Using ICD-10 Code D04.70 for Carcinoma in situ of skin of unsp lower limb, including hip
What are the risk factors for carcinoma in situ of the skin?
Risk factors include excessive sun exposure, fair skin, a history of skin cancer, and immunosuppression. Individuals with these factors should undergo regular skin examinations.
How is carcinoma in situ treated?
Treatment options include surgical excision, cryotherapy, and topical chemotherapy. The choice of treatment depends on the lesion's characteristics and patient factors.
Is carcinoma in situ of the skin contagious?
No, carcinoma in situ is not contagious. It is a localized skin condition resulting from cellular changes, not an infectious disease.
How often should patients with carcinoma in situ be monitored?
Patients should have regular follow-up appointments, typically every 3 to 6 months, to monitor for any changes in the lesion or the development of new lesions.
Clinical Notes
SOAP notes
DAP notes
AI medical notes